Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             224 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 41 Accrual to lung cancer clinical trials – a single centre experience Plant, R.
 2014
 83 S1 p. S15-S16
2 p.
 artikel
2 144 A comparison of pre-trial QA versus ongoing QA for the CONVERT trial Groom, N.
 2014
 83 S1 p. S53-
1 p.
 artikel
3 167 A comparison of the efficiency of delivery between 10MV FFF VMAT versus conventional 6MV VMAT for lung SABR and the impact on a busy radiotherapy department Moore, K.
 2014
 83 S1 p. S61-
1 p.
 artikel
4 7 Acquired resistance to TKIs in NSCLC; detection of low level T790M using an LNA clamp sequencing method Scott, P.
 2014
 83 S1 p. S3-
1 p.
 artikel
5 205 Adjuvant chemotherapy for non-small cell lung cancer: Does VATS lobectomy deliver on its promises? Paul, I.
 2014
 83 S1 p. S76-
1 p.
 artikel
6 40 Adjuvant chemotherapy in non-small cell lung cancer Al Fahad, A.
 2014
 83 S1 p. S15-
1 p.
 artikel
7 220 A feasibility randomised controlled trial looking at the effect on lung cancer diagnosis of giving a chest X-ray to smokers aged over 60 with new chest symptoms – the ELCID trial Neal, R.D.
 2014
 83 S1 p. S81-S82
2 p.
 artikel
8 18 A high EGFR mutation rate in rural Suffolk: The West Suffolk Hospital experience Lynskey, D.
 2014
 83 S1 p. S7-S8
2 p.
 artikel
9 101 A lung cancer and mesothelioma patient focus group Savory, S.
 2014
 83 S1 p. S37-S38
2 p.
 artikel
10 138 A Lung Cancer Team pilot study on pulmonary nodule surveillance Morgan, S.
 2014
 83 S1 p. S50-S51
2 p.
 artikel
11 91 An analysis of the current management practices of radically treatable non-small cell lung cancer at St James's University Hospital Beder, D.
 2014
 83 S1 p. S34-
1 p.
 artikel
12 17 An audit comparing two different cisplatin schedules and subsequent nephrotoxicity for two different schedules used in concurrent chemoradiation: Sequential Or Concurrent Chemotherapy And Radiotherapy (SOCCAR) regime for inoperable non-small cell lung cancer Wakeham, K.
 2014
 83 S1 p. S7-
1 p.
 artikel
13 14 An evaluation of toxicity and outcomes in West of Scotland patients receiving second line treatment of non-small cell lung cancer Laskey, J.
 2014
 83 S1 p. S5-S6
2 p.
 artikel
14 208 A new number for the VATS lobectomy learning curve Berman, M.
 2014
 83 S1 p. S76-S77
2 p.
 artikel
15 165 An investigation into the efficacy and toxicity of stereotactic ablative body radiotherapy for lung cancer at The Christie NHS Foundation Trust Elsesser, S.
 2014
 83 S1 p. S60-S61
2 p.
 artikel
16 221 A phase II trial to assess the safety and immunological activity of TroVax plus pemetrexed/cisplatin in patients with malignant pleural mesothelioma. The SKOPOS trial Lester, J.F.
 2014
 83 S1 p. S82-
1 p.
 artikel
17 156 Apical tumours concurrent chemoradiation and radiation dose to spinal cord Sullivan, E.
 2014
 83 S1 p. S57-
1 p.
 artikel
18 139 Are lymphocytic pleural effusions predictive of significant pathology? Allos, B.
 2014
 83 S1 p. S51-
1 p.
 artikel
19 25 A retrospective analysis of patients with advanced EGFR mutated lung cancer treated with either first line erlotinib or gefitinib Thillai, K.
 2014
 83 S1 p. S10-
1 p.
 artikel
20 82 A retrospective cohort study analysing the differences in care and treatment of patients with lung cancer based on age Ratnayake, G.
 2014
 83 S1 p. S31-
1 p.
 artikel
21 143 A review of changes in lung radiotherapy treatment techniques during the CONVERT trial Groom, N.
 2014
 83 S1 p. S52-
1 p.
 artikel
22 180 A review of treatment of limited stage small cell lung carcinoma at the Kent Oncology Centre Sevitt, T.
 2014
 83 S1 p. S66-S67
2 p.
 artikel
23 A1 Semirigid medical thoracoscopy (MT): diagnostic yield and pleurodesis success Khan, B.
 2014
 83 S1 p. S82-S83
2 p.
 artikel
24 111 A service redesign project addressing lung cancer follow up – the Lung Cancer CNS team contribution Horne, N.
 2014
 83 S1 p. S40-
1 p.
 artikel
25 36 A six year review of toxicity in patients receiving vinorelbine with platinum as adjuvant chemotherapy for non-small cell lung cancer (NSCLC) – A single institution experience: University Hospital of North Staffordshire Jegannathen, A.
 2014
 83 S1 p. S14-
1 p.
 artikel
26 89 Assessing the processes of specialist palliative care provision for patients with newly diagnosed lung cancer Ryan, S.
 2014
 83 S1 p. S33-S34
2 p.
 artikel
27 113 Assisting cancer management by reducing and avoiding hospital admissions: the Nurse Practitioner's role in the management of malignant pleural effusion Eaton-Smith, M.
 2014
 83 S1 p. S41-
1 p.
 artikel
28 125A The impact of lung cancer nurse specialists on access to anti-cancer treatment – implications for the Multidisciplinary Team (MDT) Tod, A.M.
 2014
 83 S1 p. S45-
1 p.
 artikel
29 214 A trial in design: CORE – Conventional Care or Radioablation in the treatment of Extracranial metastases Aitken, K.
 2014
 83 S1 p. S79-
1 p.
 artikel
30 105 Audit of lung cancer support groups Cochrane, B.
 2014
 83 S1 p. S39-
1 p.
 artikel
31 150 Audit of use of palliative radiotherapy and survival for patients with lung cancer in a new radiotherapy department over two years Hollingdale, A.E.
 2014
 83 S1 p. S55-
1 p.
 artikel
32 120 Audit to show the role of independent non medical prescribing in patients with lung cancer Holland, L.
 2014
 83 S1 p. S43-
1 p.
 artikel
33 Author index 2014
 83 S1 p. S84-S90
7 p.
 artikel
34 51 Bronchoscopy with endobronchial ultrasound in patients with suspected lung cancer recurrence or progression following treatment Evison, M.
 2014
 83 S1 p. S19-
1 p.
 artikel
35 54 Can sonographic characteristics during EBUS-TBNA predict lymph node metastases in lung cancer? A prospective study Evison, M.
 2014
 83 S1 p. S20-
1 p.
 artikel
36 16 Characterising the use and impact of bisphosphonates in patients with bone metastases from non-small cell lung cancer; a single centre experience Beddowes, E.J.
 2014
 83 S1 p. S6-S7
2 p.
 artikel
37 137 Characteristics of smoking behaviour in patients post curative resection of a primary lung cancer Smyth, R.
 2014
 83 S1 p. S50-
1 p.
 artikel
38 39 Chemotherapy for PS 0-1 stage IIIb/IV NSCLC: are we treating enough patients in Cardiff? Harrett, E.
 2014
 83 S1 p. S15-
1 p.
 artikel
39 177 Chemotherapy treatment rates and survival are strongly related to speed of pathway in SCLC Beckett, P.
 2014
 83 S1 p. S65-
1 p.
 artikel
40 3 Chromosomal and mutational analysis of the cisplatin resistant phenotype in NSCLC Barr, M.P.
 2014
 83 S1 p. S2-
1 p.
 artikel
41 49 Clinical utility of EBUS-TBNA histology samples for EGFR mutation analysis in primary lung adenocarcinoma Jeyabalan, A.
 2014
 83 S1 p. S18-S19
2 p.
 artikel
42 84 Community Pharmacy Referrals Project (CoPhaR): Increasing awareness and early diagnosis of respiratory disease via a direct pathway to secondary care Punwani, R.
 2014
 83 S1 p. S31-S32
2 p.
 artikel
43 142 Concurrent chemoradiation for lung cancer in a North of England population – are we managing toxicities appropriately? Mahtab, N.
 2014
 83 S1 p. S52-
1 p.
 artikel
44 185 CONVERT – a successful international collaboration between the UK NCRI, Groupe Français de Pneumo-Cancérologie, Spanish Lung Cancer Group, EORTC and NCI Canada Faivre-Finn, C.
 2014
 83 S1 p. S69-
1 p.
 artikel
45 9 Co-targeting the PI3K and MEK pathways in NSCLC: an in vitro evaluation and mutation prevalence in an Irish patient cohort Heavey, S.
 2014
 83 S1 p. S4-
1 p.
 artikel
46 109 Creating additional clinic capacity in new lung cancer clinics by use of an advanced nurse practitioner Diver, C.
 2014
 83 S1 p. S40-
1 p.
 artikel
47 44 CT guided lung biopsy: complications and positive histological diagnosis Hett, K.L.
 2014
 83 S1 p. S17-
1 p.
 artikel
48 110 Delivering better supportive care to people with lung cancer McPhelim, J.
 2014
 83 S1 p. S40-
1 p.
 artikel
49 86 Detect Cancer Early (DCE) in Scotland: an analysis of early stage lung cancer in Lothian Stoker, R.
 2014
 83 S1 p. S32-
1 p.
 artikel
50 10 Development and characterization of a panel of NSCLC cell lines resistant to PI3K/mTOR inhibitor GDC-0980 Heavey, S.
 2014
 83 S1 p. S4-
1 p.
 artikel
51 107 Development of an intervention to support patients with lung cancer share news of their diagnosis with family and friends Ewing, G.
 2014
 83 S1 p. S39-
1 p.
 artikel
52 122 Development of ‘Living well’ – A health and wellbeing programme for thoracic cancer patients Tindale-Paul, P.
 2014
 83 S1 p. S44-
1 p.
 artikel
53 77 Diagnosing, staging, management and support of patients diagnosed with malignant mesothelioma in the Yorkshire Cancer Network – a survey of MDT members Bolton, S.
 2014
 83 S1 p. S29-
1 p.
 artikel
54 56 Distribution of metastatic disease in emergency presentation of lung cancer – the reason for poorer outcome? Eaden, J.
 2014
 83 S1 p. S21-
1 p.
 artikel
55 57 Does the inclusion of MRI brain as part of the lung cancer staging pathway identify patients with asymptomatic brain metastases: avoiding inappropriate radical treatment? Eruchie, D.
 2014
 83 S1 p. S21-
1 p.
 artikel
56 148 Dose escalation in the I-START trial – ISoToxic Accelerated RadioTherapy in locally advanced non-small cell lung cancer Nixon, L.S.
 2014
 83 S1 p. S54-
1 p.
 artikel
57 157 Dosimetric impact of using spiral versus axial CT data sets for defining GTV and whole lung volume in lung cancer Chiu, Ma.
 2014
 83 S1 p. S57-S58
2 p.
 artikel
58 90 Dundee Edinburgh Cancer Informatics Program Harnessing Excellent Research (DECIPHER) – Lung cancer clinical analytics & big data Knight, R.
 2014
 83 S1 p. S34-
1 p.
 artikel
59 70 Early diagnostic yield of mycobacterial testing in patients at risk of lung cancer O'Connell, C.
 2014
 83 S1 p. S26-
1 p.
 artikel
60 76 Early experience of a regional mesothelioma MDT in the West of Scotland Tsim, S.
 2014
 83 S1 p. S28-S29
2 p.
 artikel
61 52 EBUS-TBNA in elderly patients with lung cancer: safety and performance outcomes Evison, M.
 2014
 83 S1 p. S19-S20
2 p.
 artikel
62 Editorial Board 2014
 83 S1 p. iii-
1 p.
 artikel
63 134 Effective treatment options in the management of brain metastases in lung cancer Cook, S.
 2014
 83 S1 p. S49-
1 p.
 artikel
64 21 EGFR mutation analysis in NSCLC: improving the testing rate Ho, A.L.K.
 2014
 83 S1 p. S8-S9
2 p.
 artikel
65 11 EGFR mutation demographics and unusual variants in the Scottish non-small cell lung cancer population Steele, N.
 2014
 83 S1 p. S4-S5
2 p.
 artikel
66 19 EGFR mutation rate in TRANSCRIPT: A study to assess the incidence of EGFR mutations in UK NSCLC patients with newly diagnosed locally advanced or metastatic disease. A single arm, open label study Lewanski, C.
 2014
 83 S1 p. S8-
1 p.
 artikel
67 116 Emerging roles in lung cancer care – an exploration of the work of unregistered practitioners Guerin, M.
 2014
 83 S1 p. S42-
1 p.
 artikel
68 104 Enabling tailored lung cancer information provision with the development of a new lung cancer information pack Dickson, J.
 2014
 83 S1 p. S38-
1 p.
 artikel
69 191 Enhanced recovery in thoracic surgery – a survey of national practice Wotton, R.
 2014
 83 S1 p. S71-
1 p.
 artikel
70 80 Epigenetic readers and writers as therapeutic targets in malignant pleural mesothelioma Breslin, M.
 2014
 83 S1 p. S30-
1 p.
 artikel
71 141 Evaluating the efficacy of thoracoscopy and talc poudrage versus pleurodesis using talc slurry (the TAPPS trial) Bhatnagar, R.
 2014
 83 S1 p. S51-S52
2 p.
 artikel
72 211 Excision of the primary in stage IV non-small cell lung cancer (NSCLC): A feasibility study Dawson, A.G.
 2014
 83 S1 p. S78-
1 p.
 artikel
73 153 FDG-PET parameters as predictors for outcome in non-small cell lung cancer (NSCLC) treated with stereotactic ablative radiotherapy (SABR) at the St James's Institute of Oncology Alzouebi, M.
 2014
 83 S1 p. S56-
1 p.
 artikel
74 129 Fibreoptic bronchoscopic electrocautery for palliation in patients with central lung cancer Adlakha, S.
 2014
 83 S1 p. S47-
1 p.
 artikel
75 178 First line chemotherapy for SCLC: The West of Scotland SCLC retrospective database Slater, S.
 2014
 83 S1 p. S65-S66
2 p.
 artikel
76 194 Follow up after lung cancer surgery: plain chest X ray does not increase diagnostic accuracy Hussain, A.
 2014
 83 S1 p. S72-
1 p.
 artikel
77 62 Gastrointestinal incidental findings of PET CT done for lung cancer and their follow up Johnstone, J.
 2014
 83 S1 p. S23-
1 p.
 artikel
78 98 Guidance for the assessment of patients following palliative radiotherapy for lung cancer Borthwick, D.
 2014
 83 S1 p. S36-S37
2 p.
 artikel
79 203 Guideline for telephone follow up for patients undergoing thoracic surgery Beattie, V.
 2014
 83 S1 p. S75-
1 p.
 artikel
80 202 Guidelines to prepare and support patients undergoing a lung resection Beattie, V.
 2014
 83 S1 p. S75-
1 p.
 artikel
81 88 Haemoptysis referrals with a normal CT scan can be seen safely in a monthly haemoptysis clinic – results of a retrospective audit Tanner, K.
 2014
 83 S1 p. S33-
1 p.
 artikel
82 209 High procedure volume is strongly associated with improved survival after lung cancer surgery Lüchtenborg, M.
 2014
 83 S1 p. S77-
1 p.
 artikel
83 59 Histological confirmation rate may not be a valid measure of the quality of a lung cancer MDT Conn, A.
 2014
 83 S1 p. S22-
1 p.
 artikel
84 174 Hypofractionated high dose palliative thoracic radiotherapy in non-small cell lung cancer: 36 Gy in 6 fractions (6F) alternate days over 2 weeks – a safe and efficient regimen Murray, P.
 2014
 83 S1 p. S64-
1 p.
 artikel
85 93 Hyponatraemia in lung cancer: an audit of recognition and management Simonian, S.M.
 2014
 83 S1 p. S35-
1 p.
 artikel
86 127 Identifying characteristics of patients diagnosed with lung cancer during emergency admission to hospital Calvert, L.D.
 2014
 83 S1 p. S46-
1 p.
 artikel
87 75 Immunotherapy of malignant pleural mesothelioma using MET specific T-cells Thayaparan, T.
 2014
 83 S1 p. S28-
1 p.
 artikel
88 96 Impact of an acute oncology service in patients with a suspected new diagnosis of lung cancer at University Hospitals of Leicester Walter, H.S.
 2014
 83 S1 p. S36-
1 p.
 artikel
89 85 Impact of a national Lung Cancer Awareness Campaign in Merseyside Maguire, J.
 2014
 83 S1 p. S32-
1 p.
 artikel
90 95 Impact of lung cancer acute oncology admissions in London Newsom-Davis, T.
 2014
 83 S1 p. S35-S36
2 p.
 artikel
91 195 Impact on service of a change in Oxford lung cancer follow-up protocol Teh, E.
 2014
 83 S1 p. S72-
1 p.
 artikel
92 169 Implementation of Monte Carlo dose calculation for lung SABR plan evaluation: impact on tumour coverage and dose prescription Wells, E.
 2014
 83 S1 p. S62-S63
2 p.
 artikel
93 135 Improving lung cancer outcomes in the West of Scotland McDowell, G.
 2014
 83 S1 p. S49-S50
2 p.
 artikel
94 4 Inhibition of PARP activity by PJ34 sensitises NSCLC cells to cisplatin Barr, M.P.
 2014
 83 S1 p. S2-
1 p.
 artikel
95 168 Introduction of stereotactic ablative body radiotherapy (SABR) for early stage non-small cell lung cancer (NSCLC) at a tertiary referral centre – the Birmingham experience Stevenson, R.
 2014
 83 S1 p. S62-
1 p.
 artikel
96 161 Investigation of a patient reported outcome tool to assess radiotherapy-related toxicity in patients with lung cancer Christodoulou, M.
 2014
 83 S1 p. S59-
1 p.
 artikel
97 58 Is It Really Lung Cancer? An audit of patients without a histological diagnosis, but who are treated with non-surgical radical intent for lung cancer Robertson, F.
 2014
 83 S1 p. S21-S22
2 p.
 artikel
98 215 Isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC) – a feasibility study Faivre-Finn, C.
 2014
 83 S1 p. S79-S80
2 p.
 artikel
99 172 Issues encountered in implementing stereotactic ablative body radiotherapy (SABR) for NSCLC at Nottingham University Hospitals (NUH) Foweraker, K.
 2014
 83 S1 p. S63-
1 p.
 artikel
100 176 Less chemotherapy and poor outcomes for people with small-cell lung cancer diagnosed through emergency admission Powell, H.A.
 2014
 83 S1 p. S65-
1 p.
 artikel
101 179 Limited stage small cell lung cancer (LS SCLC) – South East Wales experience Tanguay, J.S.
 2014
 83 S1 p. S66-
1 p.
 artikel
102 217 Lung ART: Phase III study comparing post-operative conformal radiotherapy to no post-operative radiotherapy in patients with completely resected non-small cell lung cancer and mediastinal N2 involvement Faivre-Finn, C.
 2014
 83 S1 p. S80-S81
2 p.
 artikel
103 124 Lung cancer clinical trials and the involvement of the lung cancer nurse specialist McPhelim, J.
 2014
 83 S1 p. S44-S45
2 p.
 artikel
104 114 Lung Cancer CNS role in management of pulmonary nodules: An All Wales Lung Cancer Forum consensus document Morgan, S.
 2014
 83 S1 p. S41-S42
2 p.
 artikel
105 83 Lung cancer diagnosis and management in patients over 80 years – An audit of practice in Kent for 2011/2012 Brown, C. O'Hanlon
 2014
 83 S1 p. S31-
1 p.
 artikel
106 42 Lung cancer diagnosis in the acute setting Lees, C.
 2014
 83 S1 p. S16-
1 p.
 artikel
107 136 Lung cancer from symptoms to referral across the Lancashire and South Cumbria Network Leyakath Ali Khan, S.
 2014
 83 S1 p. S50-
1 p.
 artikel
108 126 Lung cancer hospital admissions … Why are our patients dying in hospital? Williams, R.
 2014
 83 S1 p. S46-
1 p.
 artikel
109 103 Lung Cancer Patient Experience Survey 2013 Clayton, K.
 2014
 83 S1 p. S38-
1 p.
 artikel
110 64 Lung cancer presenting via the cancer of unknown primary assessment service at Newcastle upon Tyne Hospitals NHS Foundation Trust Jones, C.
 2014
 83 S1 p. S24-
1 p.
 artikel
111 55 Lung cancer presenting with symptomatic bone metastases: Are we doing enough? Thillai, K.
 2014
 83 S1 p. S21-
1 p.
 artikel
112 94 Lung nodule surveillance programme (LNSP) in a cancer unit: Lung cancer team experience from Bedford Hospital, UK Jeffs, Y.P.
 2014
 83 S1 p. S35-
1 p.
 artikel
113 190 Lung resections in the very elderly Teh, E.
 2014
 83 S1 p. S70-S71
2 p.
 artikel
114 171 Lung stereotactic ablative radiotherapy (SABR) for medically inoperable peripheral Stage I NSCLC at the St. James's Institute of Oncology Ramasamy, S.
 2014
 83 S1 p. S63-
1 p.
 artikel
115 50 Mediastinal staging of lung cancer at King's College Hospital – an audit over 2 years Heitmann, A.
 2014
 83 S1 p. S19-
1 p.
 artikel
116 222 MesobanK – a UK based bioresource for malignant mesothelioma Rintoul, R.C.
 2014
 83 S1 p. S82-
1 p.
 artikel
117 6 Microdroplet digital PCR in detecting mutational events in cell-free DNA in patients with lung cancer – a pilot study Gao, F.
 2014
 83 S1 p. S3-
1 p.
 artikel
118 5 MicroRNA profiling and characterisation of putative cancer stem cells in cisplatin resistant NSCLC MacDonagh, L.
 2014
 83 S1 p. S2-S3
2 p.
 artikel
119 13 Molecular profiling of non-small cell lung cancer (NSCLC) – the liquid biopsy comes of age Pender, A.
 2014
 83 S1 p. S5-
1 p.
 artikel
120 154 Morbidity and mortality following radical radiotherapy treatment for non-small cell lung cancer Abdelhalim, M.A.
 2014
 83 S1 p. S57-
1 p.
 artikel
121 155 Multi-modality treatment of Pancoast tumours: a review of regional practice Smith, E.F.
 2014
 83 S1 p. S57-
1 p.
 artikel
122 22 Mutation profiling of non-small cell lung cancer small biopsy samples using mass spectrometry and the SequenomLungCarta Panel Quinn, A.M.
 2014
 83 S1 p. S9-
1 p.
 artikel
123 30 Nintedanib (BIBF 1120) + docetaxel as second-line therapy in patients with stage IIIB/IV or recurrent NSCLC: results of the phase III, randomised, double-blind LUME-Lung 1 trial Reck, M.
 2014
 83 S1 p. S12-
1 p.
 artikel
124 119 Nurse led management of pleural effusions Davies Macmillan, C.A.
 2014
 83 S1 p. S43-
1 p.
 artikel
125 118 Nurse led pleural service Whittingham, J.
 2014
 83 S1 p. S43-
1 p.
 artikel
126 24 Outcome in metastatic NSCLC without EGFR and KRAS mutation treated with second line erlotinib Dua, D.
 2014
 83 S1 p. S10-
1 p.
 artikel
127 78 Outcomes of patients with malignant peritoneal mesothelioma at the University Hospital of South Manchester King, J.
 2014
 83 S1 p. S29-
1 p.
 artikel
128 123 Overcoming recruitment challenges in lung cancer research Jackson, N.
 2014
 83 S1 p. S44-
1 p.
 artikel
129 218 Palliative radiotherapy in malignant pleural mesothelioma. Introducing the SYSTEMS study MacLeod, N.
 2014
 83 S1 p. S81-
1 p.
 artikel
130 193 Patterns of disease recurrence and modality of detection following surgery for early stage lung cancer Brown, J.
 2014
 83 S1 p. S71-S72
2 p.
 artikel
131 38 Patterns of relapse and detection method in patients with resected non-small cell lung cancer (NSCLC) – a single institution experience Pender, A.
 2014
 83 S1 p. S15-
1 p.
 artikel
132 34 Pemetrexed and carboplatin (PC) doublet in advanced non squamous non-small cell lung cancer. Real life experience from a cancer unit Jessop, S.
 2014
 83 S1 p. S13-
1 p.
 artikel
133 2 p53 gene status and modulation of response to cisplatin chemotherapy in non-small cell lung cancer cells Barr, M.P.
 2014
 83 S1 p. S1-
1 p.
 artikel
134 72 Physician thoracoscopy in a district general hospital: report on five years' experience Venn, R.M.
 2014
 83 S1 p. S26-S27
2 p.
 artikel
135 121 Physiotherapy rehabilitation of patients following major chest wall resection: the Birmingham Heartlands experience Agostini, P.
 2014
 83 S1 p. S43-S44
2 p.
 artikel
136 216 PIT: A phase III trial of Prophylactic Irradiation of Tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention Bayman, N.
 2014
 83 S1 p. S80-
1 p.
 artikel
137 73 Pleural fluid – Time to switch off the Light's? Knight, R.
 2014
 83 S1 p. S27-
1 p.
 artikel
138 184 Potential prognostic role for the neutrophil to lymphocyte ratio in patients receiving concurrent chemo-radiotherapy for small cell lung carcinoma Murray, L.J.
 2014
 83 S1 p. S68-
1 p.
 artikel
139 92 Predictors of early death from lung cancer in primary care O'Dowd, E.
 2014
 83 S1 p. S34-S35
2 p.
 artikel
140 131 Preferred place of care in thoracic cancer patients within the palliative care service covering South Ribble, Preston and Chorley Knight, R.
 2014
 83 S1 p. S47-S48
2 p.
 artikel
141 173 Preliminary results of patients (pts) treated with SABR for early stage non-small cell lung cancer in Nottingham Radiotherapy Centre Foweraker, K.
 2014
 83 S1 p. S64-
1 p.
 artikel
142 198 Preoperative optimisation of patients undergoing lobectomy using an electronic media based exercise program Thirkettle, H.
 2014
 83 S1 p. S73-
1 p.
 artikel
143 199 Prognostic implications of blood tests performed routinely prior to surgical resection of non-small cell lung cancer Smith, M.O.
 2014
 83 S1 p. S73-S74
2 p.
 artikel
144 213 Pulmonary metastasectomy in colorectal cancer (PulMiCC) Treasure, T.
 2014
 83 S1 p. S78-S79
2 p.
 artikel
145 162 Quality of life after treatment for inoperable brain metastases from non-small cell lung cancer: An update on the Medical Research Council QUARTZ randomised clinical trial Mulvenna, P.
 2014
 83 S1 p. S59-
1 p.
 artikel
146 145 Radical chemoradiation in non-small cell lung cancer – does the number of chemotherapy cycles matter? Sambasivan, K.
 2014
 83 S1 p. S53-
1 p.
 artikel
147 133 Radiological histological features and clinical outcome of lung cancer with coexistent idiopathic pulmonary fibrosis Khan, K.A.
 2014
 83 S1 p. S49-
1 p.
 artikel
148 99 Raising the awareness of the signs and symptoms of lung cancer to the general public. A collaboration between the British Lung Foundation (BLF) and the Lung Cancer CNS Team at Guy's and St Thomas' NHS Trust Watts, E.
 2014
 83 S1 p. S37-
1 p.
 artikel
149 60 Rate and reasons of no histological diagnosis in a single centre audit of all lung cancer patients Das, K.
 2014
 83 S1 p. S22-
1 p.
 artikel
150 197 Re-audit of guideline compliance for preoperative assessment of lung cancer patients Shah, R.
 2014
 83 S1 p. S73-
1 p.
 artikel
151 65 Re-audit of referrals to Rapid Access Chest Clinic (RAC) Sheel, F.L.
 2014
 83 S1 p. S24-
1 p.
 artikel
152 117 Representing lung cancer: an examination of UK media stories Moore, S.
 2014
 83 S1 p. S42-S43
2 p.
 artikel
153 130 Retrospective audit of 2 Week Wait (2WW) clinic patient information leaflet Barfoot, J.
 2014
 83 S1 p. S47-
1 p.
 artikel
154 32 Review of pemetrexed with platinum chemotherapy for locally advanced or metastatic non squamous non-small cell lung cancer (NSCLC) in Northern Ireland Forde, C.
 2014
 83 S1 p. S13-
1 p.
 artikel
155 27 Risk of CNS progression in EGFR mutation positive NSCLC patients treated with TKI Walter, H.S.
 2014
 83 S1 p. S11-
1 p.
 artikel
156 151 Safety and survival of high dose palliative radiotherapy for locally advanced lung cancer O'Cathail, S.M.
 2014
 83 S1 p. S55-S56
2 p.
 artikel
157 43 Screening for ALK-rearranged NSCLC in selected cases using immunohistochemistry followed by FISH and RT-PCR testing of tumours with increased ALK protein expression in a routine clinical diagnostic setting Quinn, A.M.
 2014
 83 S1 p. S16-S17
2 p.
 artikel
158 175 Second line chemotherapy for recurrent SCLC: The West of Scotland SCLC retrospective database Slater, S.
 2014
 83 S1 p. S64-S65
2 p.
 artikel
159 147 Sequential chemotherapy and continuous hyperfractionated accelerated radiotherapy (CHART) for non-small cell lung cancer (NSCLC): experience from nine UK centres Bradshaw, A.G.
 2014
 83 S1 p. S54-
1 p.
 artikel
160 35 Service evaluation: Efficacy and safety of 3rd and 4th line single-agent pemetrexed in the treatment of non-squamous NSCLC Lee, A.
 2014
 83 S1 p. S13-S14
2 p.
 artikel
161 102 Sharing Bad News: Understanding the communication processes of a lung cancer diagnosis Ngwenya, N.B.
 2014
 83 S1 p. S38-
1 p.
 artikel
162 67 Short term effects of the national lung cancer screening programme in East Cheshire Farrer, B.
 2014
 83 S1 p. S25-
1 p.
 artikel
163 189 Should patients undergoing surgery for primary lung cancer receive thromboprophylaxis in order to reduce the risk of venous thromboembolism? – A systematic review Wotton, R.
 2014
 83 S1 p. S70-
1 p.
 artikel
164 29 Single network experience of the efficacy of weekly carboplatin and paclitaxel as second line treatment for metastatic thymoma and thymic carcinoma Soultati, A.
 2014
 83 S1 p. S12-
1 p.
 artikel
165 181 Small-cell lung cancer: chemotherapy cycles and survival Powell, H.A.
 2014
 83 S1 p. S67-
1 p.
 artikel
166 69 Solitary pulmonary nodules (SPN) – are we using resources wisely? Calvert, L.D.
 2014
 83 S1 p. S25-S26
2 p.
 artikel
167 81 Stage distribution of newly diagnosed patients in a UK regional mesothelioma centre Khan, S.
 2014
 83 S1 p. S30-
1 p.
 artikel
168 166 Stereotactic ablative body radiotherapy (SABR) for early lung cancer: implementation and outcomes at University College London Hospital Osborn, K.
 2014
 83 S1 p. S61-
1 p.
 artikel
169 61 Streamlining of the lung cancer diagnostic pathway in a district hospital: the result of good teamwork Diver, C.
 2014
 83 S1 p. S23-
1 p.
 artikel
170 45 Success and complication of CT biopsy of the lung in a regional teaching hospital Hunter, C.
 2014
 83 S1 p. S17-
1 p.
 artikel
171 108 Successful development of a nurse led thoracic surgical follow-up clinic for lung cancer patients Mitchell, J.
 2014
 83 S1 p. S39-S40
2 p.
 artikel
172 196 Surgery after concurrent chemo-radiation with 55 Gy in 20 fractions over four weeks with full dose platinum and vinorelbine Maguire, J.
 2014
 83 S1 p. S72-S73
2 p.
 artikel
173 219 Surgical and large bore pleural interventions in malignant pleural mesothelioma and radiotherapy trial (the SMART trial) Clive, A.O.
 2014
 83 S1 p. S81-
1 p.
 artikel
174 201 Surgical resection rates for early stage non-small cell lung cancer following PETCT Thomas, B.
 2014
 83 S1 p. S74-
1 p.
 artikel
175 149 Survival following radiotherapy for lung cancer in patients aged 80 and over in the West of Scotland: a retrospective audit Attia, H.
 2014
 83 S1 p. S55-
1 p.
 artikel
176 182 Survival in stage IV small cell lung cancer and effect of prophylactic cranial irradiation Hett, K.L.
 2014
 83 S1 p. S67-S68
2 p.
 artikel
177 187 Survival of small cell lung cancer patients undergoing lung resection in England 1998-2009 Lüchtenborg, M.
 2014
 83 S1 p. S70-
1 p.
 artikel
178 1 Targeting NF-κB regulated pathways to overcome cisplatin resistance in non-small cell lung cancer Baird, A.-M.
 2014
 83 S1 p. S1-
1 p.
 artikel
179 20 Testing for epidermal growth factor (EFGR) mutation in non-small cell lung cancer (NSCLC) patients; the Heart of England NHS Foundation Trust (HEFT) experience Kussaibati, R.
 2014
 83 S1 p. S8-
1 p.
 artikel
180 212 Testing the feasibility of establishing a cohort of lung cancer patients to investigate recovery following surgery with curative intent Foster, C.
 2014
 83 S1 p. S78-
1 p.
 artikel
181 47 The ability of a filter-based antibody-independent approach to capture circulating tumour cells for the diagnosis of lung cancer Freydina, D.V.
 2014
 83 S1 p. S17-S18
2 p.
 artikel
182 37 The assessment of performance status: a review of our clinical practice Harrett, E.
 2014
 83 S1 p. S14-S15
2 p.
 artikel
183 100 The “CLiC” cough in lung cancer study: Co-morbidities are key predictors of cough Harle, A.S.M.
 2014
 83 S1 p. S37-
1 p.
 artikel
184 125 The effects of the molecular targeted therapies in advanced lung and renal cancer focus group analysis Magee, L.R.A.
 2014
 83 S1 p. S45-
1 p.
 artikel
185 140 The efficacy of indwelling pleural catheter (IPC) placement versus IPC placement PLUS sclerosant (talc) in patients with malignant pleural effusions managed exclusively as out-patients (the IPC-PLUS trial) Bhatnagar, R.
 2014
 83 S1 p. S51-
1 p.
 artikel
186 207 The epidemiology of lung resections – changes over a ten year period Ramaesh, R.
 2014
 83 S1 p. S76-
1 p.
 artikel
187 97 The experience of lung cancer patients seeking treatment through Accident and Emergency Departments (AED) Crane, J.
 2014
 83 S1 p. S36-
1 p.
 artikel
188 210 The first UK audit of curative-intent radiotherapy for non-small cell lung cancer; the need to assess quality and improve outcomes McAleese, J.
 2014
 83 S1 p. S77-S78
2 p.
 artikel
189 63 The impact of a new rapid access pleural out-patients service Grundy, S.
 2014
 83 S1 p. S23-S24
2 p.
 artikel
190 152 The impact of IMRT on the treatment of patients with N3M0 lung cancer at The Christie Prasad, N.
 2014
 83 S1 p. S56-
1 p.
 artikel
191 160 The impact of peer review on the radiotherapy treatment planning process in the treatment of lung cancer Rooney, K.P.
 2014
 83 S1 p. S58-S59
2 p.
 artikel
192 128 The impact of the Acute Oncology Service (AOS) on emergency admissions of lung cancer patients to a West Midlands hospital Herring, K.
 2014
 83 S1 p. S46-S47
2 p.
 artikel
193 74 The importance of accurate pre-operative biopsy in the radical management of mesothelioma – Don't blame the physician just keep taking more bites Sharkey, A.
 2014
 83 S1 p. S27-S28
2 p.
 artikel
194 170 The introduction of stereotactic ablative radiotherapy increases overall radical treatment rates for stage I lung cancer but does not reduce surgical resection rates – a single centre study Cheyne, L.
 2014
 83 S1 p. S63-
1 p.
 artikel
195 200 The natural history of carcinoma-in-situ at the bronchial resection margin Apperley, H.
 2014
 83 S1 p. S74-
1 p.
 artikel
196 106 The patient experience of lung cancer in Scotland Borthwick, D.
 2014
 83 S1 p. S39-
1 p.
 artikel
197 68 The prevalence of hyponatraemia amongst patients with newly diagnosed thoracic malignancies Thillai, K.
 2014
 83 S1 p. S25-
1 p.
 artikel
198 163 The retreatment of thoracic malignancies with curative doses of external beam radiotherapy – a case series Leaning, D.J.
 2014
 83 S1 p. S60-
1 p.
 artikel
199 53 The role of endobronchial ultrasound guided transbronchial needle aspiration Reid, P.A.
 2014
 83 S1 p. S20-
1 p.
 artikel
200 115 The role of the lung cancer care coordinator Moore, A.
 2014
 83 S1 p. S42-
1 p.
 artikel
201 206 The role of VATS segmentectomy for early stage lung cancer Will, M.
 2014
 83 S1 p. S76-
1 p.
 artikel
202 79 The RON (MST1R)/MSP pathway is a potential therapeutic target in malignant pleural mesothelioma Baird, A.-M.
 2014
 83 S1 p. S29-S30
2 p.
 artikel
203 23 The use of erlotinib in patients with EGFR wild type adenocarcinoma of the lung in the Beatson West of Scotland Cancer Centre – retrospective evaluation Aleksic, A.
 2014
 83 S1 p. S9-S10
2 p.
 artikel
204 33 The use of pemetrexed for the first-line treatment of non-small cell lung cancer Silva, S.
 2014
 83 S1 p. S13-
1 p.
 artikel
205 31 The use of pemetrexed in advanced non-small cell lung cancer Ng, C.
 2014
 83 S1 p. S12-
1 p.
 artikel
206 146 The use of stereotactic radiotherapy for the treatment of brain metastasis in patients with non-small cell lung cancer: a decade of experience from Bristol Oncology Centre Harris, L.
 2014
 83 S1 p. S53-S54
2 p.
 artikel
207 48 The utility of chest X-rays in the diagnosis of lung cancer Fowles, H.
 2014
 83 S1 p. S18-
1 p.
 artikel
208 8 The utility of peripheral blood circulating tumour cells for the detection of KRAS, EGFR and BRAF mutations in primary lung cancer Freidin, M.B.
 2014
 83 S1 p. S3-S4
2 p.
 artikel
209 158 Thoracic radiotherapy planning: Where's the heart? Crossley, R.
 2014
 83 S1 p. S58-
1 p.
 artikel
210 164 Thoracic stereotactic body radiotherapy (SABR) in patients who previously had curative treatment for lung cancer Choong, E.S.
 2014
 83 S1 p. S60-
1 p.
 artikel
211 192 Thoracic Surgery Patient Experience Day (TSPED) Sharman, J.
 2014
 83 S1 p. S71-
1 p.
 artikel
212 159 Towards validation of breath-hold ventilation CT for NSCLC radiotherapy planning Tahir, B.A.
 2014
 83 S1 p. S58-
1 p.
 artikel
213 183 Treating extensive stage small cell lung carcinoma in poor performance status patients – is a high 30 day mortality rate justifiable? Bird, T.
 2014
 83 S1 p. S68-
1 p.
 artikel
214 26 Treatment and outcome in epidermal growth factor receptor mutant non-small cell lung cancer: A retrospective audit across four NHS trusts Killick, E.
 2014
 83 S1 p. S10-S11
2 p.
 artikel
215 71 Twelve months experience of a telephone clinic follow up service for incidental pulmonary nodules Ibison, K.
 2014
 83 S1 p. S26-
1 p.
 artikel
216 66 UK Lung Cancer Screening trial (UKLS): Prevalence data at baseline Field, J.K.
 2014
 83 S1 p. S24-S25
2 p.
 artikel
217 112 Understanding the value of the lung cancer nurse specialist White, J.
 2014
 83 S1 p. S40-S41
2 p.
 artikel
218 132 Undiagnosed COPD in patients with suspected lung cancer Cusworth, K.E.
 2014
 83 S1 p. S48-
1 p.
 artikel
219 15 Use of blood transfusions in patients receiving vinorelbine or gemcitabine with carboplatin for advanced non-small cell lung cancer Tufail, A.
 2014
 83 S1 p. S6-
1 p.
 artikel
220 186 Use of tolvaptan, a new V2 receptor antagonist, in the treatment of syndrome of inappropriate antidiuretic hormone secretion (SIADH) secondary to small cell lung cancer (SCLC) – a case series Fraser, I.M.
 2014
 83 S1 p. S69-
1 p.
 artikel
221 87 Variance from radiology follow-up protocol after surgical resection of NSCLC Smith, M.O.
 2014
 83 S1 p. S33-
1 p.
 artikel
222 12 VEGF autocrine survival signalling is mediated via neuropilin 1 receptor in NSCLC cells Barr, M.P.
 2014
 83 S1 p. S5-
1 p.
 artikel
223 204 Video-assisted thoracoscopic lobectomy enhances recovery and reduces the need for physiotherapy interventions compared to open thoracotomy Agostini, P.
 2014
 83 S1 p. S75-S76
2 p.
 artikel
224 28 Why are patients not receiving day 8 gemcitabine? A single centre review Davies, R.S.
 2014
 83 S1 p. S11-
1 p.
 artikel
                             224 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland